Effects of N-Substituted Analogs of Benztropine: Diminished Cocaine-Like Effects in Dopamine Transporter Ligands
- 30 January 2004
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 309 (2), 650-660
- https://doi.org/10.1124/jpet.103.060525
Abstract
Previous studies demonstrated that analogs of benztropine (BZT) possess high affinity for the dopamine transporter, inhibit dopamine uptake, but generally have behavioral effects different from those of cocaine. One hypothesis is that muscarinic-M1 receptor actions interfere with cocaine-like effects. Several tropane-nitrogen substitutions of 4′,4′′-diF-BZT have reduced M1 affinity compared with the CH3-analog (AHN 1-055; 3α-[bis-(4-fluorophenyl)methoxy]tropane). All of the compounds displaced [3H]WIN 35,428 (2β-carbomethoxy-3β-(4-fluorophenyl)tropane) binding with affinities ranging from 11 to 108 nM. Affinities at norepinephrine ([3H]nisoxetine) and serotonin ([3H]citalopram) transporters ranged from 457 to 4810 and 376 to 3260 nM, respectively, and at muscarinic M1 receptors ([3H]pirenzepine) from 11.6 (AHN 1-055) to higher values, reaching 1030 nM for the other BZT-analogs. Cocaine and AHN 1-055 produced dose-related increases in locomotor activity in mice, with AHN 1-055 less effective than cocaine. The other compounds were ineffective in stimulating activity. In rats discriminating cocaine (29 μmol/kg i.p.) from saline, WIN 35,428 fully substituted for cocaine, whereas AHN 1-055 produced a maximal substitution of 79%. None of the other analogs fully substituted for cocaine. WIN 35,428 produced dose-related leftward shifts in the cocaine dose-effect curve, whereas selected BZT analogs produced minimal changes in the effects of cocaine. The results suggest that reducing M1 affinity of 4′,4′′-diF-BZT with N-substitutions reduces effectiveness in potentiating the effects of cocaine. Furthermore, although the BZT-analogs bind with high affinity at the dopamine transporter, their behavioral effects differ from those of cocaine. These compounds have reduced efficacy compared with cocaine, a long duration of action, and may serve as leads for the development of medications to treat cocaine abuse.Keywords
This publication has 22 references indexed in Scilit:
- Behavioral effects of rimcazole analogues alone and in combination with cocaineEuropean Journal of Pharmacology, 2003
- Locomotor stimulant effects of novel phenyltropanes in the mouseDrug and Alcohol Dependence, 2001
- Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.Psychopharmacology, 2001
- Differential interaction of GBR 12909, a dopamine uptake inhibitor, with cocaine and methamphetamine in rats discriminating cocainePsychopharmacology, 2001
- Novel N-Substituted 3α-[Bis(4‘-fluorophenyl)methoxy]tropane Analogues: Selective Ligands for the Dopamine TransporterJournal of Medicinal Chemistry, 1997
- 3‘-Chloro-3α-(diphenylmethoxy)tropane But Not 4‘-Chloro-3α- (diphenylmethoxy)tropane Produces a Cocaine-like Behavioral ProfileJournal of Medicinal Chemistry, 1997
- Highly potent cocaine analogs cause long-lasting increases in locomotor activityEuropean Journal of Pharmacology, 1996
- Cocaine and 3.beta.-(4'-Substituted phenyl)tropane-2.beta.-carboxylic Acid Ester and Amide Analogs. New High-Affinity and Selective Compounds for the Dopamine TransporterJournal of Medicinal Chemistry, 1995
- The dopamine hypothesis of the reinforcing properties of cocaineTrends in Neurosciences, 1991
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973